|
Login
Logo

ICPACT is a collaborative platform that aims to integrate ACT researchers and institutions to advance pediatric ACT research.

The initiative led by Bonald C. Figueiredo (Pequeno Principe Hospital and Research Institute, Curitiba, Brazil), is focused on mapping new members who are dedicated to integrating pediatric ACT research, securing funding for a structured ICPACT website, periodical Workshops hosted by each member and organizing multi-institutional projects.

Under new leadership by Camila Daiggi (starting in November 2024) the goals include launching "The Stage II Project" at the Boldrini Research Center (Campinas – SP, Brazil), implementing the REDCap Boldrini system, convening all ACT researchers and families in an international workshop at the Boldrini Center in November 2024 sponsored by CNRS-IPMC (PI Enzo Lalli), and empowering members to coordinate in different departments (pre-clinical research, clinics, genetics, pathology, epidemiology, etc).

ACT Meetings in 2024

  • ECE 2024 (European Society of Endocrinology) – 11-14 May 2024 

https://www.ese-hormones.org/education-and-training/european-congress-of-endocrinology/ece-2024

  • XIXth International Adrenal Meeting – 29-31 May 2024 

https://www.eventsquid.com/event.cfm?id=22293

  • ENDO 2024 – 1-4 June 2024 

https://www.endocrine.org/meetings-and-events/endo-2024

  • SLEP 11-14 September 2024 
  • 9th international ACC symposium 22-23 November 2024 

Texas (not yet online). 

  • European Network for the Study of AdrenalTumours (ENSAT) – 2-4 October 2024, Palma de Mallorca, Spain.  

ENS@T – Joint 23rd ENS@T scientific meeting and 3rd Harmonis@tion meeting

  • ICPACT I – 7-9 November 2024, Boldrini Research Center (Pediatric Oncology), Campinas, São Paulo, Brazil. Programme and registration available in May, 2024. 

Disclaimer

"The information on this website is provided for informational purposes only by adrenocortical tumor researchers, and should not take the place of the advice or recommendations of your physician. Users should be aware that by accessing and using these web pages, users assume the risk that the information and documentation contained on these web pages may be offensive, inaccurate, and/or incomplete, and/or may not meet the needs and requirements of the user. The entire risk as to the use of this website is assumed by the User. ICPACT shall not be liable for any damages suffered by the users of this site, or documentation found on this website.”